1152
D. Liu et al. / Tetrahedron 70 (2014) 1149e1153
4. Experimental section
130.0 (q, JCeF¼32.5 Hz), 128.9, 127.1, 126.5, 125.9 (q, JCeF¼3.8 Hz),
125.2, 124.2, 123.9 (q, JCeF¼272.5 Hz).
4.1. General information
4.3.6. 5-(Naphthalen-2-yl)-2-phenyloxazole (3fa, Table 3).34 White
Chemicals were either purchased or purified by standard tech-
niques. 1H NMR and 13C NMR spectra were measured on a 500 MHz
spectrometer (1H 500 MHz, 13C 125 MHz) with CDCl3 as the solvent
at room temperature. Chemical shifts (in ppm) were referenced to
solid; 1H NMR (CDCl3, 500 MHz):
d
¼8.18e8.16 (m, 3H), 7.91e7.87
(m, 2H), 7.85e7.74 (m, 2H), 7.55e7.48 (m, 6H); 13C NMR (CDCl3,
125 MHz):
d¼161.3, 151.3, 133.4, 133.1, 130.3, 128.8, 128.7, 128.2,
127.8, 127.5, 126.8, 126.5, 126.3, 125.3, 124.0, 122.9, 122.0.
tetramethylsilane (
were obtained by using the same NMR spectrometer and were
d
¼0 ppm) or CHCl3 (7.26 ppm). 13C NMR spectra
4.3.7. 2-Phenyl-5-(thiophen-2-yl)oxazole (3ga, Table 3).36 Greenish
calibrated with CDCl3
(
d
¼77.00 ppm). Chemical shifts are given in
solid;
7.35e7.34 (m, 1H), 7.31 (s, 1H), 7.11e7.09 (m, 1H); 13C NMR (CDCl3,
125 MHz):
d
¼8.10e8.08 (m, 2H), 7.50e7.46 (m, 3H), 7.38e7.37 (m, 1H),
d
relative to TMS, the coupling constants J are given in hertz (Hz).
Column chromatography was performed using EM Silica gel 60
(300e400 mesh).
d¼160.6, 146.8, 130.4, 129.9, 128.8, 127.8, 127.2, 126.3,
125.6, 124.3, 123.1.
4.3.8. 5-(Furan-2-yl)-2-phenyloxazole (3ha, Table 3).34 White solid;
4.2. General procedure to oxazoles from chalcone and ben-
zylic amine
1H NMR (CDCl3, 500 MHz):
d
¼8.09e8.08 (m, 2H), 7.47 (d, J¼1.5 Hz,
4H), 7.35 (s, 1H), 6.70 (d, J¼3.0 Hz, 1H), 6.53e6.52 (m, 1H); 13C NMR
(CDCl3, 125 MHz):
d
¼160.7, 143.8, 143.7, 142.9, 130.4, 128.8, 127.2,
Under O2, a mixture of chalcone (0.2 mmol), benzylamine
(0.4 mmol), CuBr2 (20 mol %), pyridine (0.4 mmol), K2CO3
(0.1 mmol), and LiBr (0.5 mmol) in dry toluene (2 mL) was refluxed
at 110 ꢀC for 11 h. After the completion of the reaction, as monitored
by TLC, the solvent was concentrated under vacuum and the resi-
due was purified by flash column chromatography through silica
gel (300e400 mesh) with petroleum ether/EtOAc as eluant to give
the desired product.
126.4, 123.4, 111.6, 107.3.
4.3.9. 2-(2-Chlorophenyl)-5-phenyloxazole (3ab, Table
2).26 Yellowish solid; 1H NMR (CDCl3, 500 MHz):
d
¼8.12e8.09
(m, 1H), 7.75e7.74 (m, 2H), 7.55e7.53 (m, 2H), 7.45 (t, J¼8.0 Hz, 2H),
7.39e7.34 (m, 3H); 13C NMR (CDCl3,125 MHz):
d¼159.0,151.7,132.3,
131.3, 131.0, 130.7, 129.0, 128.6, 127.8, 126.9, 126.2, 124.3, 123.2.
4.3.10. 2-(3-Bromophenyl)-5-phenyloxazole (3ac, Table
47
4.3. Synthesis of deuterated substrates 4eMeC6H4CD2NH2
2).35 Yellowish solid; 1H NMR (CDCl3, 500 MHz):
d
¼8.25e8.24
(m, 1H), 8.05e8.03 (m, 1H), 7.73e7.72 (m, 2H), 7.59e7.57 (m, 1H),
Compound 4eMeC6H4CD2NH2 was synthesized by reduction of
4-methylbenzonitrile (0.52 g, 5 mmol) with lithium aluminum
deuteride (0.5 g, 5 mmol) in ice cooled dry ether (50 ml). The
mixture was refluxed for 4 h before cooling to 0 ꢀC, EtOAc (0.4 mL)
was added to dilute the reaction. After filtration, the filter cake was
washed with ether, evaporated under vacuum (25 ꢀC) to afford p-
tolylmethanamine as a colorless oil. The isotopic purity determined
by 1H NMR was 95%.
7.47e7.44 (m, 3H), 7.37e7.34 (m, 2H); 13C NMR (CDCl3, 125 MHz):
d
¼159.6, 151.7, 133.2, 130.4, 129.2, 129.1, 129.0, 128.7, 127.7, 124.7,
124.3, 123.6, 122.9.
4.3.11. 2-(4-Chlorophenyl)-5-phenyloxazole (3ad, Table
2).26 Yellowish solid; 1H NMR (CDCl3, 500 MHz):
d
¼8.04 (d, J¼8.5
Hz, 2H), 7.71 (d, J¼8.0 Hz, 2H), 7.47e7.44 (m, 5H), 7.32 (t, J¼7.5 Hz,
1H); 13C NMR (CDCl3, 125 MHz):
d¼160.2, 151.5, 136.4, 129.1, 129.0,
128.6, 127.8, 127.5, 125.9, 124.2, 123.5.
4.3.1. 2,5-Diphenyloxazole (3aa).34 Yellow solid; 1H NMR (CDCl3,
500 MHz):
d
¼8.13e8.11 (m, 2H), 7.73e7.72 (m, 2H), 7.51e7.43 (m,
4.3.12. 2-(4-Fluorophenyl)-5-phenyloxazole (3ae, Table
6H), 7.36e7.33 (m, 1H); 13C NMR (CDCl3, 125 MHz):
d¼161.1, 151.2,
2).35 Yellowish solid; 1H NMR (CDCl3, 500 MHz):
d
¼8.10e8.07 (m,
2H), 7.71e7.69 (m, 2H), 7.45e7.42 (m, 3H), 7.35e7.32 (m, 1H),
7.18e7.14 (m, 2H); 13C NMR (CDCl3, 125 MHz):
130.2, 128.8, 128.7, 128.3, 128.0, 127.4, 126.2, 124.1, 123.4.
d
¼165.0 (d,
4.3.2. 5-(4-Bromophenyl)-2-phenyloxazole (3ba, Table
JCeF¼249.5 Hz), 160.3, 151.3, 128.9, 128.4 (d, JCeF¼11.5 Hz), 128.3,
3).34 Yellowish solid; 1H NMR (CDCl3, 500 MHz):
d
¼8.11e8.09 (m,
2H), 7.59e7.56 (m, 4H), 7.49e7.45 (m, 4H); 13C NMR (CDCl3,
125 MHz):
127.9, 124.2, 123.8 (d, JCeF¼3.3 Hz), 123.4, 116.0 (d, JCeF¼22.1 Hz).
d
¼161.4, 150.3, 132.1, 130.5, 128.8, 127.3, 127.0, 126.4,
4.3.13. 2-(3-Fluorophenyl)-5-phenyloxazole (3af, Table
2). Yellowish solid, mp: 68e70 ꢀC; 1H NMR (CDCl3, 500 MHz):
125.6, 123.9, 122.3.
d
¼7.90 (d, J¼8.0 Hz, 1H), 7.80 (d, J¼9.5 Hz, 1H), 7.72 (d, J¼7.5 Hz,
2H), 7.46 (t, J¼7.5 Hz, 4H), 7.36 (t, J¼7.5 Hz, 1H), 7.18e7.14 (m, 1H);
13C NMR (CDCl3, 125 MHz):
4.3.3. 2-Phenyl-5-(p-tolyl)oxazole (3ca, Table 3).35 White solid; 1H
NMR (CDCl3, 500 MHz):
7.50e7.45 (m, 3H), 7.40 (s, 1H), 7.26e7.24 (m, 2H), 2.39 (s, 3H); 13
NMR (CDCl3, 125 MHz): 160.8, 151.5, 138.5, 130.2, 129.6, 128.8,
127.5, 126.2, 125.3, 124.2, 122.8, 21.4.
d
¼8.11e8.09 (m, 2H), 7.61 (d, J¼8.5 Hz, 2H),
d¼162.9 (d, JCeF¼244.8 Hz), 159.4, 151.7,
C
130.5 (d, JCeF¼8.1 Hz), 129.0, 128.7, 127.7, 124.3, 123.6, 122.0 (d,
JCeF¼3.0 Hz), 117.2 (d, JCeF¼21.3 Hz), 113.2 (d, JCeF¼23.8 Hz); IR
(prism, cmꢁ1): 1593, 1543, 1481, 1267, 1191, 940, 791; HRMS calcd
for C15H11FNO ([MþH]þ): 240.0819; found: 240.0800.
d
4.3.4. 5-(4-Methoxyphenyl)-2-phenyloxazole (3da, Table
3).36 Yellow solid; 1H NMR (CDCl3, 500 MHz):
¼8.09 (d, J¼8.5
d
4.3.14. 5-Phenyl-2-(m-tolyl)oxazole (3ag, Table 2).26 Yellowish
Hz, 2H), 7.66 (d, J¼8.5 Hz, 2H), 7.49e7.45 (m, 3H), 7.33 (s, 1H), 6.97
solid; 1H NMR (CDCl3, 500 MHz):
d
¼7.94e7.91 (m, 2H), 7.73 (d,
(d, J¼9.0 Hz, 2H), 3.86 (s, 3H); 13C NMR (CDCl3, 125 MHz):
d
¼160.6,
J¼7.0 Hz, 2H), 7.47e7.44 (m, 3H), 7.39e7.33 (m, 2H), 7.27 (d,
159.8, 151.3, 130.1, 128.8, 127.6, 126.1, 125.7, 122.0, 120.9, 114.4, 55.4.
J¼7.5 Hz, 1H), 2.45 (s, 3H); 13C NMR (CDCl3, 125 MHz):
¼161.3,
d
151.2, 138.6,131.1, 128.9, 128.7, 128.4,128.1,127.3, 126.8,124.2, 123.4,
123.4, 21.4.
4.3.5. 2-Phenyl-5-(4-(trifluoromethyl)phenyl)oxazole (3ea, Table
3).45 White solid; 1H NMR (CDCl3, 500 MHz):
d
¼8.14e8.12(m, 2H)
7.82 (d, J¼8.0 Hz, 2H), 7.69 (d, J¼8.0 Hz, 2H), 7.56 (s, 1H), 7.51e7.49
(m, 3H); 13C NMR (CDCl3, 125 MHz):
¼162.0, 149.8, 131.2, 130.7,
4.3.15. 5-Phenyl-2-(p-tolyl)oxazole (3ah, Table 2).26 Yellowish
d
solid; 1H NMR (CDCl3, 500 MHz):
d¼7.99 (d, J¼8.0 Hz, 2H), 7.69 (d,